Tissue-derived droplet micro-organospheres as models for high-throughput testing of pathogens
Ended Definitive Contract Awarded Last action
- Contract number
- HR001121C0093
- Awardee
-
Xilis Inc. UEI HUBZGFA8NE97
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $224,658
Award facts
- Opportunity
-
- Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Pre-Solicitation · HR001120S0019 · Posted Feb 12, 2020
- Friend or Foe Award Notice · Posted Mar 9, 2021
- Contract value 100% obligated
- $224,658.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Chapel Hill, NC 27514, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $224,658 |
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Xilis Inc., a for-profit manufacturing organization. The contract is for the development of tissue-derived droplet micro-organospheres as models for high-throughput testing of pathogens, with a total potential value of $224,658.00. The contract has a firm fixed price pricing type and a completion date of August 31, 2021. The original solicitation was a Broad Agency Announcement from DARPA seeking proposals for SBIR and Small Business Technology Transfer (STTR) funding opportunities to advance DARPA's mission across various technical domains.
Quick answers
Who was awarded contract HR001121C0093?
HR001121C0093 was awarded to Xilis Inc. by Defense Advanced Research Projects Agency (Department of Defense) on February 26, 2021.
How much is contract HR001121C0093 worth?
The government has obligated $224,658 on HR001121C0093.
Was contract HR001121C0093 competed?
The extent of competition for HR001121C0093 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award